Lucía García-González

Lucía García-González

Auto-generated profile, based on publicly available information

Lucía García-González

Department of Urology, University Hospital 12 de Octubre, Madrid, Spain

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in Urology
Verified
Journal Article
Closed access
JOJavier Romero Otero
Javier Romero Otero
LGLucía García-González
Lucía García-González
BGBorja García-Gómez
Borja García-Gómez
JJJuan Justo-Quintas
Juan Justo-Quintas
EGEsther García-Rojo
Esther García-Rojo
ARAlfredo Rodríguez-Antolín
Alfredo Rodríguez-Antolín

5 February 2020 in BJU International
Verified
Journal Article
Closed access
PDF file
JOJavier Romero Otero
Javier Romero Otero
BGBorja García Gómez
Borja García Gómez
LGLucía García‐González
Lucía García‐González
EGEsther García‐Rojo
Esther García‐Rojo
PAPablo Abad‐López
Pablo Abad‐López
ARAlfredo Rodríguez‐Antolín
Alfredo Rodríguez‐Antolín

1 June 2015 in Urology
Verified
Journal Article
Closed access
JOJavier Romero Otero
Javier Romero Otero
JMJosé Medina-Polo
José Medina-Polo
BGBorja García-Gómez
Borja García-Gómez
DLDavid Lora-Pablos
David Lora-Pablos
JDJosé Manuel Duarte-Ojeda
José Manuel Duarte-Ojeda
ARAlfredo Rodríguez-Antolín
Alfredo Rodríguez-Antolín

25 July 2013 in Scandinavian Journal of Urology
Verified
Journal Article
Closed access
PDF file
JMJosé Medina-Polo
José Medina-Polo
EJEstíbaliz Jiménez-Alcaide
Estíbaliz Jiménez-Alcaide
LGLucía García-González
Lucía García-González
Félix Guerrero-RamosFélix Guerrero-Ramos
Félix Guerrero-Ramos
SPSantiago Pérez-Cadavid
Santiago Pérez-Cadavid
ÁTÁngel Tejido-Sánchez
Ángel Tejido-Sánchez
Objective. Healthcare-associated infections (HAIs) constitute a potentially severe complication which implies higher costs. A full knowledge of their microbiological characteristics and risk factors is of paramount importance for adequate management. The purpose of this study was to carry out an analysis of HAIs in patients admitted to a department of urology. Material and methods. Between November 2011 and October 2012, a prospective observational study was carried out analysing HAIs in patients admitted to the urology department of a tertiary care university hospital in Spain, reviewing the incidence and types of HAIs, the microorganisms isolated and patterns of resistance to antibiotics. Risk factors for HAIs were also evaluated. Results. HAIs were seen in 110 (6.5%) out of 1701 patients. Hypertension, a higher American Society of Anesthesiologists (ASA) score and surgery showed a statistical association with a higher risk of HAIs, and patients who underwent radical cystectomy had a high incidence of HAIs (10 out of 14). The most common HAIs were urinary tract infections (66.1%), followed by surgical site infections (16.5%), intra-abdominal abscesses (10.4%) and venous catheter-associated bacteraemia (6.1%). The most frequently isolated microorganisms were Escherichia coli (31.8%), then Enterococcus (17.6%) and Pseudomonas (12.9%). Escherichia coli showed resistance rates of 48.1% for ampicillin/amoxicillin plus β-lactamase inhibitor, 51.9% for fluoroquinolones, and 33.3% were extended-spectrum β-lactamase-producing E. coli. Pseudomonas aeruginosa showed a resistance rate of 36.4% for fluoroquinolones and carbapenems. Conclusions. HAIs usually occur in patients with risk factors. Radical cystectomy is associated with a high incidence of HAIs. Microorganisms associated with HAIs show high rates of resistance, which must be taken into account when selecting appropriate antibiotic therapy.

12 April 2018 in Urologia Internationalis
Verified
Journal Article
Closed access
PDF file
RSRaquel Sopeña-Sutil
Raquel Sopeña-Sutil
JMJosé Medina-Polo
José Medina-Polo
JJJuan Justo-Quintas
Juan Justo-Quintas
JGJavier Gil-Moradillo
Javier Gil-Moradillo
LGLucia Garcia-Gonzalez
Lucia Garcia-Gonzalez
ATAngel Tejido-Sanchez
Angel Tejido-Sanchez
Objectives: To review the incidence of healthcare-associated infections/urinary tract infection (UTI), risk factors, microorganisms isolated and antibiotic resistances in patients who underwent lower urinary tract endoscopic surgery (LUTES) in a tertiary care hospital. Methods: A prospective observational study was carried out including 1,498 patients who undergo LUTES. Patients with and without UTI after surgery were compared. We analysed infection incidence, risk factors, microorganisms isolated and antibiotic resistances. Results: Postoperative UTI incidence was 4.7%. Risk factors found: higher American Society of Anesthesiologists classification (OR 2.82; 95% CI 1.8–4.5; p < 0.00), immunosuppression (OR 2.89; 95% CI 1.2–7.2; p = 0.01), indwelling urinary catheter prior admission (OR 2.6; 95% CI 1.6–4.2; p < 0.00) and postoperative catheterization longer than 2 days (OR 1.74; 95% CI 1.7–4.3; p < 0.00). Transurethral resection of the bladder (TURB) had the highest infection rates (5.5%). Microorganisms isolated were Pseudomonas aeruginosa (23.5%), Escherichia coli (17.6%), Klebsiella pneumoniae and Enterococcus spp (11.8%). Resistance rates for flourquinolones varied between 28 and 80%, and Carbapenem-resistant Enterobacteriaceae rose up 20%. Conclusions: Low percentage of UTI after endoscopic surgery was registered. TURB was the procedure with highest infection rate. Pseudomonas aeruginosa stands out as the most frequently isolated microorganism. Patient comorbidities, previous urinary catheter and postoperative catheter were identified as risk factors.

1 July 2019 in Journal of Endourology
Verified
Journal Article
Closed access
JOJavier Romero Otero
Javier Romero Otero
LGLucía García González
Lucía García González
BGBorja García-Gómez
Borja García-Gómez
MAManuel Alonso-Isa
Manuel Alonso-Isa
EGEsther García-Rojo
Esther García-Rojo
ARAlfredo Rodríguez-Antolín
Alfredo Rodríguez-Antolín
Purpose: To assess the influence of holmium laser cystolitholapaxy (HLC) concomitantly with holmium laser prostate enucleation (HoLEP) on patients with benign prostatic hyperplasia (BPH) presenting bladder calculi. Materials and Methods: We present a retrospective analysis of patients with BPH (with or without concomitant HLC) at three Spanish centers. Intraoperative variables (e.g., time and resected tissue), changes in functional parameters of the prostate, and frequency of complications (intraoperative, early postoperative, and at 12 months) in patients with and without HLC were compared. Results: The analysis included 963 patients aged 48 to 91 years, of which 54 (5.6%) underwent HLC to treat vesical lithiasis. Mean (range) prostate size (measured by transrectal ultrasound) was 79 (43–173) g and 91 (35–247) g for patients with and without concomitant HLC, respectively ( p = 0.080). All bladder calculi were effectively removed. No significant differences were found regarding enucleation and morcellation times, but total operation time was significantly higher in patients with HLC: mean (standard deviation [SD]) of 78 (27) minutes vs 95 (41) minutes ( p < 0.001). Three patients underwent conversion to open surgery because of bladder perforation, all of them from the group without HLC. Rates of intraoperative, early, and 12-month complications were similar in both groups. No significant differences in International Prostate Symptom Scale, maximum flow rate (Qmax), and mean flow were observed between groups 12 months after surgery. Conclusions: Simultaneous HoLEP and HLC increases the total operation time, but does not influence the risk of clinically relevant perioperative and postoperative complications.